Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals efficacy differences between home-based 308-nm LED and hospital-based 308-nm MEL in treating pediatric vitiligo.
Introduction Vitiligo, a common depigmentation disorder, is often treated with phototherapy. 308‐nm monochromatic excimer lamp/laser (308‐nm MEL) is typically administered in hospitals, whereas 308‐nm light‐emitting diodes (308‐nm LED) offer a home‐based alternative. This study compared the efficacy and safety of home‐based 308‐nm LED with hospital‐based 308‐nm MEL in pediatric vitiligo. Methods A retrospective analysis of 75 pediatric vitiligo patients treated with home‐based 308‐nm LED or hospital‐based 308‐nm MEL was conducted. Efficacy (repigmentation > 50%) and adverse events were evaluated after 16, 32, and 48 sessions. Statistical analyses were performed using SPSS 25.0. Results After 48 sessions, hospital‐based 308‐nm MEL showed higher efficacy rates (79.5%) than home‐based 308‐nm LED (38.9%, p < 0.001). However, efficacy was similar when cumulative doses were comparable ( p > 0.05). Adverse events were more frequent in the home‐based group (63.9% vs. 30.8%, p = 0.029), likely due to cautious dose adjustments. Shorter disease duration and stable disease correlated with better outcomes ( p < 0.05). Conclusion Home‐based 308‐nm LED is a viable alternative to hospital‐based 308‐nm MEL for pediatric vitiligo when cumulative doses are similar. However, higher adverse events in home‐based therapy highlight the need for better patient education and professional guidance. AI and digital platforms could enhance the safety and efficacy of home‐based phototherapy.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: